Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 49 - Preparations for testing in vivo
Patents for A61K 49 - Preparations for testing in vivo (35,376)
09/2014
09/25/2014US20140286870 Rapid infusion of autologous bone marrow derived stem cells
09/25/2014US20140286869 Rapid infusion of autologous bone marrow derived stem cells
09/25/2014US20140286868 Immortalized human prostate cell lines
09/25/2014US20140286867 Use of tnfalpha inhibitor for treatment of erosive polyarthritis
09/25/2014US20140286866 Imaging agents with improved pharmacokinetic profiles
09/25/2014US20140286865 Synthetic diblock copolypeptide hydrogels for use in the central nervous system
09/25/2014US20140286864 Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
09/25/2014US20140286863 Complexation of Fatty Acid-Conjugated Molecules with Albumin
09/25/2014US20140286862 Therapeutic Agents and Uses Thereof
09/24/2014EP2780041A1 Multimodal contrast and radiopharmaceutical agent for an imaging and a targeted therapy guided by imaging
09/23/2014US8840905 Use of neurotoxin therapy for treatment of urologic and related disorders
09/23/2014US8840877 Polysaccharide-protein conjugates reversibly coupled via imine bonds
09/23/2014US8840874 Vascular delivery systems
09/23/2014US8840868 Non-invasive detection of complement-mediated inflammation using CR2-targeted nanoparticles
09/23/2014US8840867 Embolizing sclerosing hydrogel
09/23/2014US8840865 Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof
09/18/2014WO2014145885A1 System and method for identification of breast ductal network
09/18/2014WO2014145573A1 Coated magnetic nanoparticles for imaging enhancement and drug delivery
09/18/2014WO2014145509A1 Enteric ct contrast material based on low-z atoms
09/18/2014WO2014145257A2 Activity-based probe compounds, compositions, and methods of use
09/18/2014WO2014144685A2 Methods for identifying arthropod repellents and attractants, and compounds and compositions identified by such methods
09/18/2014WO2014144633A1 System and method for improved high dose radiation therapy treatment planning
09/18/2014WO2014144365A1 Nano-liposomal formulations and methods of use
09/18/2014WO2014143939A1 Myo-inositol trispyrophosphate as an anti-obesity agent
09/18/2014WO2014143763A2 Angiogenic compositions for wounds, articular joints and graft materials
09/18/2014WO2014142320A1 Novel compound, and reagent for detecting lipid droplets and/or adipose tissue containing said compound
09/18/2014WO2014141288A1 The art, method, manner, process and system of a nano-biomineral for multi-modal contrast imaging and drug delivery
09/18/2014WO2014141287A1 The art, method, manner, process and system of multifunctional nanobiomaterial for molecular imaging and drug- delivery
09/18/2014WO2014140543A1 Hypoosmotic solutions for lymph node detection
09/18/2014WO2014140203A1 Particles comprising luminescent lanthanide complexes
09/18/2014WO2014138912A1 Luminescent compounds and methods of using same
09/18/2014US20140276363 Sonochemical Induction of ABCA1 Expression and Compositions Therefor
09/18/2014US20140276107 Photodynamic diagnosis
09/18/2014US20140276035 System and Method for Evaluation of Disease Burden
09/18/2014US20140276021 Enteric ct contrast material based on low-z atoms
09/18/2014US20140275533 Methods of Manufacture and Synthesis of Amino Acid Linking Groups Conjugated To Compounds Used For Targeted Imaging of Tumors
09/18/2014US20140271688 Antibody drug conjugates
09/18/2014US20140271676 Fc containing polypeptides with altered glycosylation and reduced effector function
09/18/2014US20140271490 Bacteria-targeted magnetic resonance contrast agents
09/18/2014US20140271489 Polymeric depots for localization of agent to biological sites
09/18/2014US20140271487 Prussian blue-inspired constructs for multimodal imaging and therapy
09/18/2014US20140271486 Quantum Dots for Diagnostic Imaging
09/18/2014US20140271485 Use of coelenterazine for imaging insulin-generating beta-cells
09/18/2014US20140271484 Methods of Imaging Inflammatory Diseases by Ligands Conjugated to Fluorescent Compounds
09/18/2014US20140271483 Targeted polymeric conjugates and uses thereof
09/18/2014US20140271482 Synthesis and composition of amino acid linking groups conjugated to compounds used for the targeted imaging of tumors
09/18/2014US20140271481 Matrix-incorporated fluorescent porous and non-porous silica particles for medical imaging
09/18/2014US20140271480 Uses of indole-ketones or indolidones as neuro-protective drugs
09/18/2014US20140271479 Optogenetic control of inputs to the ventral tegmental area
09/18/2014US20140271478 Antibodies that bind integrin alpha-v beta-8
09/18/2014US20140271477 Monoclonal antibodies to egfr, and uses therefor
09/18/2014US20140271476 Synthesis and composition of amino acid linking groups conjugated to compounds used for the targeted imaging of tumors
09/18/2014US20140271475 Cellulose nanoparticle biodegradable photoacoustic contrast agents
09/18/2014US20140271470 Targeted theranostics for metastatic prostate cancer
09/18/2014US20140271468 Asthma imaging
09/17/2014EP2777715A1 Particles comprising luminescent lanthanide complexes
09/16/2014US8835484 Naphthocyanines for use as contrast agents
09/16/2014US8835172 Modular functional peptides for delivery of nanoparticles
09/16/2014US8834881 Human binding molecules capable of binding to and neutralizing influenza B viruses and uses thereof
09/16/2014US8834871 Immunoglobulin molecules with improved characteristics
09/16/2014US8834844 Chemical exchange saturation transfer based MRI using reporter genes and MRI methods related thereto
09/16/2014US8834843 Imaging method
09/16/2014US8834842 Vitamin-targeted imaging agents
09/16/2014US8834839 Labeled molecular imaging agents, methods of making and methods of use
09/16/2014US8834838 Non-invasive diagnostic agents of cancer and methods of diagnosing cancer, especially leukemia and lymphoma
09/16/2014CA2675202C Methods and compositions for improved f-18 labeling of proteins, peptides and other molecules
09/16/2014CA2614486C Contrast agent comprising a scaffold protein and a metal ion chelating site integrated therein
09/16/2014CA2607228C Compositions and methods using microspheres and non-ionic contrast agents
09/15/2014CA2845336A1 Encapsulated metal ion nanoclusters
09/12/2014WO2014138662A1 Polyphosphate-functionalized inorganic nanoparticles as hemostatic compositions and methods of use
09/12/2014WO2014138186A1 Bioorthogonal two-component delivery systems for enhanced internalization of nanotherapeutics
09/12/2014WO2014136076A2 Assembly comprising an absorber of near infrared (nir) light covalently linked to an inhibitor of carbonic anhydrase
09/12/2014WO2014135280A1 Targeted delivery of nanoparticles to epicardial derived cells (epdc)
09/11/2014US20140257100 Porphyrin Microbubbles
09/11/2014US20140257098 Systems and methods for detection of cancer in women
09/11/2014US20140257085 Process For The Preparation Of Hyperpolarized Derivatives For Use In MRI Analysis
09/11/2014US20140256837 Hydrogels that undergo volumetric expansion in response to changes in their environment and their methods of manufacture and use
09/11/2014US20140255335 Inherently radiopaque polymeric products for embolotherapy
09/11/2014US20140255317 Preparation comprising hexose-6-phosphate-modified cholesterol derivative
09/11/2014US20140255316 Biomarkers and use thereof
09/11/2014US20140255315 Acf detection method
09/11/2014US20140255313 Compositions and Methods for Detecting Protease Activity in Biological Systems
09/11/2014US20140255312 Cyanine compounds
09/11/2014US20140255311 Biocompatible polymeric nanoparticles degrade and release cargo in response to biologically relevant levels of hydrogen peroxide
09/11/2014US20140255310 Human G Protein-Coupled Receptor and Modulators Thereof for the Treatment of Atherosclerosis and Atherosclerotic Disease and for the Treatment of Conditions Related to MCP-1 Expression
09/11/2014US20140255307 Contrast medium composition and method of bio imagination using the same
09/10/2014EP2774625A1 Polymer-type fluorescent molecule probe
09/10/2014EP2773332A1 Combination of a nanoparticle comprising a charged core made of phospholipid with a protein - use for the in vitro delivery of said protein
09/09/2014US8829159 Plectin-1 targeted agents for detection and treatment of pancreatic ductal adenocarcinoma
09/09/2014US8828681 Host cells with artificial endosymbionts
09/09/2014US8828671 Simultaneous assay of target and target-drug binding
09/09/2014US8828357 Iron oxide nanoparticles as MRI contrast agents and their preparing method
09/09/2014US8828356 Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis
09/09/2014CA2692646C Contrast agents
09/04/2014WO2014132235A1 Method for the production of sub-micrometric particles and their theranostic use in oncology with a specific apparatus
09/04/2014US20140249468 Imaging agents for imaging protease activity and uses thereof
09/04/2014US20140249413 Theranosis of macrophage-associated diseases with ultrasmall superparamagnetic iron oxide nanoparticles (uspio)
09/04/2014US20140249403 Self-assembled, micropatterned, and radio frequency (rf) shielded biocontainers and their uses for remote spatially controlled chemical delivery
09/04/2014US20140249391 Tissue visualization for resection
09/04/2014US20140248218 Ros-sensitive fluorescent probes
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 ... 354